A frontline chemotherapy drug given to patients with pancreatic cancer is made less effective because similar compounds released by tumor-associated immune cells block the drug's action.
from Latest Science News -- ScienceDaily https://ift.tt/2OsEtyH
via IFTTT
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment